| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0190-9622(84)80263-7 |
| P698 | PubMed publication ID | 6715608 |
| P2093 | author name string | Bickers DR | |
| Hawkins C | |||
| Voorhees JJ | |||
| Callen JP | |||
| Hanno R | |||
| Woo TY | |||
| P2860 | cites work | Polymyositis and dermatomyositis (first of two parts) | Q33911013 |
| Anti-malarials in dermatology | Q40244962 | ||
| Dermatomyositis in six patients without initial muscle involvement | Q66875444 | ||
| Polymyositis and Dermatomyositis: Combined Methotrexate and Corticosteroid Therapy | Q69798107 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hydroxychloroquine | Q421094 |
| dermatomyositis | Q681160 | ||
| P304 | page(s) | 592-600 | |
| P577 | publication date | 1984-04-01 | |
| P1433 | published in | Journal of the American Academy of Dermatology | Q15757046 |
| P1476 | title | Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine | |
| P478 | volume | 10 |
| Q95359116 | Q95359116 |
| Q72030005 | Acquired cutaneous lymphangiectasia mimicking plantar warts |
| Q55053285 | Aminoquinoline antimalarial therapy in dermatomyositis-are we missing opportunities with respect to comorbidities and modulation of extracutaneous disease activity? |
| Q33853505 | Antihelmintic and antiparasitic drugs: unapproved uses or indications |
| Q33853468 | Antimalarials: unapproved uses or indications |
| Q36844843 | Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis |
| Q69754014 | Chloroquine-induced neutropenia in a patient with dermatomyositis |
| Q41587406 | Classification and treatment of the juvenile idiopathic inflammatory myopathies |
| Q47882674 | Clinical efficacy of intravenous immunoglobulins for the treatment of dermatomyositis skin lesions without muscle disease |
| Q77797502 | Collagen vascular diseases |
| Q38625526 | Current management of polymyositis and dermatomyositis |
| Q46902693 | Current treatments of dermatomyositis and polymyositis |
| Q47593445 | Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review |
| Q41508452 | Cutaneous clues to systemic disease |
| Q34349952 | Cutaneous dermatomyositis: an updated review of treatment options and internal associations |
| Q34112642 | Cutaneous manifestations of dermatomyositis and their management |
| Q39614364 | Dermatologic therapy: December 1983 through November 1984. |
| Q31960726 | Dermatomyositis |
| Q68183703 | Dermatomyositis |
| Q73313259 | Dermatomyositis |
| Q64954054 | Dermatomyositis: An Acute Flare and Current Treatments. |
| Q41728644 | Dermatomyositis: a dermatology-based case series |
| Q34779213 | Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects |
| Q94418532 | Effectiveness of Quinacrine (Mepacrine) in Photosensitive Autoimmune Diseases, Lupus Erythematosus, and Dermatomyositis: Report on 38 Cases and Literature Review |
| Q34124740 | Favorable outcome of juvenile dermatomyositis treated without systemic corticosteroids |
| Q51540185 | Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology. |
| Q37827403 | Hydroxychloroquine: from malaria to autoimmunity |
| Q73520766 | Idiopathic inflammatory myopathies |
| Q37208984 | Immunomodulatory treatment for dermatomyositis |
| Q35642216 | Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of Wong's dermatomyositis |
| Q38221095 | Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment. |
| Q69531786 | Juvenile dermatomyositis |
| Q37662512 | Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management |
| Q71975594 | Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis |
| Q77091376 | Management of collagen vascular diseases in childhood |
| Q38022271 | Management of cutaneous dermatomyositis. |
| Q33811532 | New and emerging therapies for collagen-vascular diseases |
| Q34007922 | New concepts in antimalarial use and mode of action in dermatology |
| Q41494480 | Paraneoplastic dermatomyositis revealing an undifferentiated nasopharyngeal carcinoma: about a case |
| Q41940295 | Pericardial tamponade in juvenile dermatomyositis |
| Q37983569 | Polymyositis: a case history approach to the differential diagnosis and treatment |
| Q41521239 | Recognition and Management of Myositis |
| Q33848574 | Review article: a therapeutic update on dermatomyositis/polymyositis |
| Q38017740 | Review of dermatomyositis: establishing the diagnosis and treatment algorithm |
| Q41946634 | Synthetic antimalarials |
| Q38561490 | Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases |
| Q44750209 | Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study |
| Q35814405 | Treatment approaches to juvenile dermatomyositis |
| Q34526090 | Treatment of Clinically Amyopathic Dermatomyositis in adults: A Systematic Review |
Search more.